TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 30780126

Group type: EXPERIMENTAL
Intervention: Diet and metformin therapy
Number of subjects: 42

Group type: COMPARATOR
Intervention: Diet alone
Number of subjects: 42
Study: 28922158

Group type: EXPERIMENTAL
Intervention: Home‐based individually‐tailored and adaptive Computerized Cognitive Training (CCT)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Active control condition (AC)
Number of subjects: 45
Study: 23737342

Group type: EXPERIMENTAL
Intervention: Chemotherapy combined with targeted arterial infusion of verapamil
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Chemotherapy combined with targeted arterial infusion of verapamil in patients with liver metastases
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Follow-up of patients
Number of subjects: 40
Study: 22153362

Group type: EXPERIMENTAL
Intervention: Nap (45 min NREM sleep)
Number of subjects: 55
Study: 20414671

Group type: EXPERIMENTAL
Intervention: Critical velocity (CV) using two-parameter model (CV(2par))
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Critical velocity (CV) using three-parameter model (CV(3par))
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Anaerobic distance capacity (ADC) using three-parameter and four-parameter models
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Maximal instantaneous velocity (V(max)) in sprint group
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Maximal instantaneous velocity (V(max)) using four-parameter model (V(max 4par))
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Aerobic inertia (tau)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Model analysis (F test, R(2), R(adjusted)(2))
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Four-parameter model correlation for endurance group
Number of subjects: 14
Study: 17873673

Group type: EXPERIMENTAL
Intervention: Oxygenated glycerol triester (OGT) oral spray (1 or 2 sprays up to 4 times daily)
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Oxygenated glycerol triester (OGT) oral spray
Number of subjects: 74

Group type: COMPARATOR
Intervention: Commercially available artificial saliva substitute (ASS)
Number of subjects: 74
Study: 15689192

Group type: EXPERIMENTAL
Intervention: Sumatriptan nasal spray administered 120 min after the onset of the attack
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Sumatriptan nasal spray
Number of subjects: 19

Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 19
Study: 12236412

Group type: EXPERIMENTAL
Intervention: Assertive community treatment (ACT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Regular outpatient and inpatient care
Number of subjects: 0
Study: 9918893

Group type: EXPERIMENTAL
Intervention: Metoprolol 50 mg twice daily
Number of subjects: 50

Group type: COMPARATOR
Intervention: Celiprolol 200 mg daily
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 7538412

Group type: EXPERIMENTAL
Intervention: Ibuprofen
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (no ibuprofen)
Number of subjects: 0
Study: 2316840

Group type: EXPERIMENTAL
Intervention: Inhaled nebulisation using a jet nebuliser
Number of subjects: 48

Group type: COMPARATOR
Intervention: Cricothyroid injection
Number of subjects: 48

Group type: COMPARATOR
Intervention: Spraying technique
Number of subjects: 48
Study: 7309300

Group type: EXPERIMENTAL
Intervention: 900 mg dihydroxydibutylether (DHBE)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 31588662

Group type: EXPERIMENTAL
Intervention: Dorsal root ganglion stimulation (DRG‐S)
Number of subjects: 17
Study: 30832739

Group type: EXPERIMENTAL
Intervention: Growth Assessment Protocol (GAP)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: GAP
Number of subjects: 0
Study: 27577956

Group type: EXPERIMENTAL
Intervention: Abdominoplasty with muscle plication
Number of subjects: 125

Group type: COMPARATOR
Intervention: Abdominoplasty without muscle plication
Number of subjects: 125

Group type: COMPARATOR
Intervention: Abdominoplasty with vs without muscle plication
Number of subjects: 125
Study: 25879810

Group type: EXPERIMENTAL
Intervention: Teaching assistant led extracurricular intervention
Number of subjects: 10
Study: 24034628

Group type: EXPERIMENTAL
Intervention: Physician prehospital care (including advanced interventions such as rapid sequence intubation and blood transfusion)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Paramedic care alone
Number of subjects: 0
Study: 21249380

Group type: EXPERIMENTAL
Intervention: High-speed boat transit (TRAN)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (CON)
Number of subjects: 24
Study: 19732415

Group type: EXPERIMENTAL
Intervention: Active management booklet for hip and knee osteoarthritis
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control booklet
Number of subjects: 120
Study: 17708159

Group type: EXPERIMENTAL
Intervention: Cold blood cardioplegia solution with PA vent and PEEP during CPB
Number of subjects: 142

Group type: COMPARATOR
Intervention: Control group with cardioplegia entering lung parenchyma
Number of subjects: 142
Study: 16282201

Group type: EXPERIMENTAL
Intervention: Spontaneous pain ratings in chronic back pain and chronic postherpetic neuropathy patients
Number of subjects: 0

Group type: COMPARATOR
Intervention: Ratings of acute thermal painful stimuli or imagined back pain by normal subjects
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: fMRI brain activity in chronic back pain patients
Number of subjects: 0
Study: 12677762

Group type: EXPERIMENTAL
Intervention: Balneokinesis (group A)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Elastic compression therapy (group B)
Number of subjects: 70
Study: 10546696

Group type: EXPERIMENTAL
Intervention: 18-lesson, 6-month classroom curriculum to reduce television, videotape, and video game use
Number of subjects: 192

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 192
Study: 8570798

Group type: EXPERIMENTAL
Intervention: Physical countermeasure (pressing the toes to the floor)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Mental countermeasure (counting backward by sevens)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (uninformed subjects)
Number of subjects: 40
Study: 1989801

Group type: EXPERIMENTAL
Intervention: IV nicardipine
Number of subjects: 122

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 122
Study: 6679435

Group type: EXPERIMENTAL
Intervention: Cefuroxime
Number of subjects: 86

Group type: COMPARATOR
Intervention: Tobramycin plus ampicillin
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Cefuroxime and carbenicillin during neutropenia
Number of subjects: 86

Group type: COMPARATOR
Intervention: Tobramycin plus ampicillin and carbenicillin during neutropenia
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Combined initial and cross-over trials
Number of subjects: 86
Study: 31908428

Group type: EXPERIMENTAL
Intervention: High-Intensity Resistance Training (HI-RT)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 43
Study: 29181392

Group type: EXPERIMENTAL
Intervention: 18-hour psychotherapeutic stress management intervention (SMI) based on the Effort‐Reward Imbalance (ERI) model
Number of subjects: 94

Group type: COMPARATOR
Intervention: External control group (n = 94)
Number of subjects: 94
Study: 26058790

Group type: EXPERIMENTAL
Intervention: Spironolactone
Number of subjects: 97

Group type: COMPARATOR
Intervention: Control (no MRAs)
Number of subjects: 97
Study: 23121249

Group type: EXPERIMENTAL
Intervention: Immunization schedule
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study: 21697300

Group type: EXPERIMENTAL
Intervention: High antioxidant spice blend (14 g) added to a 5060‐kJ (1200 kcal) meal
Number of subjects: 6

Group type: COMPARATOR
Intervention: Control meal
Number of subjects: 6
Study: 19880844

Group type: EXPERIMENTAL
Intervention: Darbepoetin alfa
Number of subjects: 4038

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4038
Study: 17085985

Group type: EXPERIMENTAL
Intervention: Statin drugs for lowering cardiovascular risk
Number of subjects: 0
Study: 15521798

Group type: EXPERIMENTAL
Intervention: 5-word TBR list
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 20-word TBR list
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 1 intervening list
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 2 intervening lists
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Reduced rehearsal
Number of subjects: 0
Study: 11275921

Group type: EXPERIMENTAL
Intervention: Enoxaparin
Number of subjects: 3275

Group type: COMPARATOR
Intervention: Unfractionated Heparin (UFH)
Number of subjects: 3275
Study: 9315315

Group type: EXPERIMENTAL
Intervention: Se-enriched yeast (200 micrograms Se/day)
Number of subjects: 1312

Group type: COMPARATOR
Intervention: Low-Se yeast placebo
Number of subjects: 1312
Study: 8378854

Group type: EXPERIMENTAL
Intervention: Acetylsalicylic acid (ASA) 125 mg/day and curantyl (150‐225 mg/day) from gestation week 12‐19 till delivery
Number of subjects: 64

Group type: COMPARATOR
Intervention: Control group (no drugs)
Number of subjects: 64
Study: 3005377

Group type: EXPERIMENTAL
Intervention: Ciprostene at a maximum dose of 160 ng/kg/min for 8 hours daily for three days.
Number of subjects: 23

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Ciprostene
Number of subjects: 23
Study: 29362248

Group type: EXPERIMENTAL
Intervention: Narrative medicine-based intervention (three 30 min talks with GPs over 12 months)
Number of subjects: 604

Group type: EXPERIMENTAL
Intervention: Narrative medicine-based intervention
Number of subjects: 604

Group type: COMPARATOR
Intervention: Care as usual (control group)
Number of subjects: 604
Study: 26406216

Group type: EXPERIMENTAL
Intervention: PA lumbar mobilization plus traditional treatment (Ultrasonic and Infra-red)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo mobilization plus traditional treatment
Number of subjects: 45

Group type: COMPARATOR
Intervention: Traditional treatment only
Number of subjects: 45
Study: 25625801

Group type: EXPERIMENTAL
Intervention: Acute strenuous exercise (cycling ergometry)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 30-minute bout of intensive exercise
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Longer (6 weeks) or chronic (1 year) increases in physical activity
Number of subjects: 0

Group type: COMPARATOR
Intervention: Obese subjects
Number of subjects: 0

Group type: COMPARATOR
Intervention: Men
Number of subjects: 0
Study: 24119487

Group type: EXPERIMENTAL
Intervention: Trauma-focused psychological counseling (verum intervention)
Number of subjects: 426

Group type: COMPARATOR
Intervention: Non-trauma focused counseling (control intervention)
Number of subjects: 426
Study: 21413975

Group type: EXPERIMENTAL
Intervention: Preoperative and postoperative docosahexaenoic acid (DHA) levels
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: Preoperative and postoperative arachidonic acid (AA) levels
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: Postoperative total n-3 long-chain polyunsaturated fatty acids (LC-PUFA) levels
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: n-3 LC-PUFA supplements
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: Arachidonic acid (AA) levels
Number of subjects: 125
Study: 18315957

Group type: EXPERIMENTAL
Intervention: MIS-AL total hip replacement
Number of subjects: 48

Group type: COMPARATOR
Intervention: Standard total hip replacement
Number of subjects: 48
Study: 16971719

Group type: EXPERIMENTAL
Intervention: Oral fingolimod 1.25 mg
Number of subjects: 281

Group type: EXPERIMENTAL
Intervention: Oral fingolimod 5.0 mg
Number of subjects: 281

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 281

Group type: EXPERIMENTAL
Intervention: Continuous fingolimod
Number of subjects: 281

Group type: EXPERIMENTAL
Intervention: Switch from placebo to fingolimod
Number of subjects: 281
Study: 12656698

Group type: EXPERIMENTAL
Intervention: 20 mg omeprazole
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: 20 mg rabeprazole
Number of subjects: 59

Group type: COMPARATOR
Intervention: Control group (healthy subjects)
Number of subjects: 59
Study: 12564272

Group type: EXPERIMENTAL
Intervention: Therapeutic massage
Number of subjects: 69

Group type: COMPARATOR
Intervention: Relaxation tape in surgery
Number of subjects: 69

Group type: COMPARATOR
Intervention: Relaxation tape at home
Number of subjects: 69
Study: 10551191

Group type: EXPERIMENTAL
Intervention: Regular telephone contact with a diabetes nurse educator for advice about adjustment of insulin therapy
Number of subjects: 46

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 46
Study: 8723578

Group type: EXPERIMENTAL
Intervention: Epoetin alfa
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 1662671

Group type: EXPERIMENTAL
Intervention: Herpes simplex type I subunit vaccine
Number of subjects: 83

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 83
Study: 6133637

Group type: EXPERIMENTAL
Intervention: Prazosin, 14.0 +/- 2.4 mg/day in three equal doses
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Prazosin
Number of subjects: 6
Study: 31014471

Group type: EXPERIMENTAL
Intervention: Alcohol (target blood alcohol concentration = 0.08%; n = 64)
Number of subjects: 128

Group type: COMPARATOR
Intervention: Nonalcoholic control beverage (n = 64)
Number of subjects: 128
Study: 29581078

Group type: EXPERIMENTAL
Intervention: Alogliptin
Number of subjects: 1398

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1398
Study: 26150543

Group type: COMPARATOR
Intervention: Placebo arm of a randomized clinical trial of Chinese medicine
Number of subjects: 45
Study: 24476781

Group type: EXPERIMENTAL
Intervention: Hyperoxia (HOX; 30.0% O2)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Normoxia (NOX; 20.9% O2)
Number of subjects: 12
Study: 22335736

Group type: EXPERIMENTAL
Intervention: Intramuscular midazolam
Number of subjects: 893

Group type: COMPARATOR
Intervention: Intravenous lorazepam
Number of subjects: 893
Study: 20222930

Group type: EXPERIMENTAL
Intervention: Cold atmospheric argon plasma treatment (5 min daily) in addition to standard wound care
Number of subjects: 36
Study: 17573449

Group type: EXPERIMENTAL
Intervention: High-intensity exercise training 3 days/week for 10 weeks
Number of subjects: 15
Study: 12410058

Group type: EXPERIMENTAL
Intervention: Olanzapine (up to 30 mg per day)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Olanzapine (high-dose)
Number of subjects: 9
Study: 9511777

Group type: EXPERIMENTAL
Intervention: Whirlpool bath at 40 degrees C
Number of subjects: 6

Group type: COMPARATOR
Intervention: User-controlled water temperature (UCT)
Number of subjects: 6
Study: 7659482

Group type: EXPERIMENTAL
Intervention: DTaP
Number of subjects: 2342

Group type: COMPARATOR
Intervention: DTP
Number of subjects: 2342
Study: 2496619

Group type: EXPERIMENTAL
Intervention: Midazolam
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Flumazenil (0.3 mg)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Midazolam-Ringer's solution
Number of subjects: 12

Group type: COMPARATOR
Intervention: Flumazenil alone
Number of subjects: 12
Study: 901629

Group type: EXPERIMENTAL
Intervention: Hypolipidaemic therapy
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 29535259

Group type: EXPERIMENTAL
Intervention: High-frequency oscillating device for respiratory muscle training (8 weeks, 3 times daily)
Number of subjects: 23
Study: 28631101

Group type: EXPERIMENTAL
Intervention: Exergame bike
Number of subjects: 73

Group type: COMPARATOR
Intervention: Standard stationary bike
Number of subjects: 73
Study: 26316701

Group type: EXPERIMENTAL
Intervention: Test ondansetron oral soluble film formulation
Number of subjects: 10

Group type: COMPARATOR
Intervention: Reference ondansetron oral soluble film formulation
Number of subjects: 10
Study: 23852061

Group type: EXPERIMENTAL
Intervention: Nitrous oxide/oxygen inhalation sedation and local anesthesia
Number of subjects: 40

Group type: COMPARATOR
Intervention: Local anesthesia
Number of subjects: 40
Study: 21425511

Group type: EXPERIMENTAL
Intervention: Anterolateral interscalene catheter
Number of subjects: 110

Group type: COMPARATOR
Intervention: Posterior interscalene catheter
Number of subjects: 110
Study: 18503607

Group type: EXPERIMENTAL
Intervention: Glyburide alone
Number of subjects: 8

Group type: COMPARATOR
Intervention: Glyburide co-administered with Sitagliptin
Number of subjects: 8
Study: 16579999

Group type: EXPERIMENTAL
Intervention: Sildenafil 100 mg
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study: 14618045

Group type: EXPERIMENTAL
Intervention: Sotalol (80 mg two times daily for five days starting from the morning of the first postoperative day)
Number of subjects: 207

Group type: EXPERIMENTAL
Intervention: Magnesium (1.5 g daily for six days starting in the operating room just before cardiopulmonary bypass)
Number of subjects: 207

Group type: EXPERIMENTAL
Intervention: Sotalol + Magnesium (both at the same dosages)
Number of subjects: 207

Group type: COMPARATOR
Intervention: Control group (no antiarrhythmic agents)
Number of subjects: 207
Study: 11419424

Group type: EXPERIMENTAL
Intervention: Early invasive strategy (routine catheterization within 4 to 48 hours)
Number of subjects: 2220

Group type: COMPARATOR
Intervention: Conservative strategy (selectively invasive, catheterization only if evidence of recurrent ischemia)
Number of subjects: 2220

Group type: EXPERIMENTAL
Intervention: Early invasive strategy
Number of subjects: 2220

Group type: COMPARATOR
Intervention: Conservative strategy
Number of subjects: 2220
Study: 9048454

Group type: EXPERIMENTAL
Intervention: Angulated abutments
Number of subjects: 71

Group type: COMPARATOR
Intervention: Standard abutments
Number of subjects: 71
Study: 8243078

Group type: EXPERIMENTAL
Intervention: Nonparametric multivariate rank test
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Randomization tests
Number of subjects: 0
Study: 3435920

Group type: EXPERIMENTAL
Intervention: Methotrexate (MTX), 40 mg/m2 iv push weekly
Number of subjects: 48

Group type: COMPARATOR
Intervention: Sequential Methotrexate and 5-fluorouracil (MTX 150 mg/m2 iv for 1 h; 5-FU 600 mg/m2 iv for 2 h; leucovorin rescue 10 mg/m2 iv and orally every 6 h 4 times, repeated every 10 days)
Number of subjects: 48
Study: 2239776

Group type: EXPERIMENTAL
Intervention: Skim milk from immunized cows
Number of subjects: 11

Group type: COMPARATOR
Intervention: Control skim milk (placebo)
Number of subjects: 11
Study: 31087685

Group type: EXPERIMENTAL
Intervention: Parent‐Infant Psychotherapy (PIP)
Number of subjects: 61
Study: 28453835

Group type: EXPERIMENTAL
Intervention: TDF-containing ART
Number of subjects: 365

Group type: COMPARATOR
Intervention: ART without TDF
Number of subjects: 365
Study: 25950425

Group type: COMPARATOR
Intervention: Placebo capsules and normal saline infusion perioperatively (control)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Placebo capsules and lidocaine 1 mg/kg intravenous bolus dose followed by 2 mg/kg/h infusion until skin closure
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: 150 mg oral pregabalin and normal saline infusion perioperatively
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: 150 mg oral pregabalin and lidocaine 2 mg/kg/h infusion until skin closure
Number of subjects: 80
Study: 23395119

Group type: EXPERIMENTAL
Intervention: One delayed intensification course
Number of subjects: 521

Group type: COMPARATOR
Intervention: Two delayed intensification courses
Number of subjects: 521
Study: 20692182

Group type: EXPERIMENTAL
Intervention: Behavioral intervention arm (Health Belief Model telephonic intervention)
Number of subjects: 227

Group type: EXPERIMENTAL
Intervention: Behavioral intervention arm
Number of subjects: 227

Group type: COMPARATOR
Intervention: Attention control arm
Number of subjects: 227
Study: 20492127

Group type: EXPERIMENTAL
Intervention: WYPF banana bread
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: WYPF biscotti
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: BYP (Boiled Yellow Peas)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: WYPF pasta
Number of subjects: 0

Group type: COMPARATOR
Intervention: WWF biscotti
Number of subjects: 0

Group type: COMPARATOR
Intervention: WB (White Bread)
Number of subjects: 0

Group type: COMPARATOR
Intervention: WWF pasta
Number of subjects: 0
Study: 17276096

Group type: EXPERIMENTAL
Intervention: Endovascular treatment
Number of subjects: 128
Study: 12850965

Group type: EXPERIMENTAL
Intervention: Men
Number of subjects: 812

Group type: EXPERIMENTAL
Intervention: Black women
Number of subjects: 812

Group type: EXPERIMENTAL
Intervention: Mid-thigh muscle area
Number of subjects: 812

Group type: EXPERIMENTAL
Intervention: Muscle area
Number of subjects: 812

Group type: EXPERIMENTAL
Intervention: Women
Number of subjects: 812

Group type: COMPARATOR
Intervention: Four groups (White men, White women, Black men, Black women)
Number of subjects: 812
Study: 10570388

Group type: EXPERIMENTAL
Intervention: Imiquimod 5% cream (dosed twice daily, once daily, and 3 times weekly)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Imiquimod 5% cream (dosed twice weekly)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Imiquimod 5% cream (dosed once weekly)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Vehicle cream (control)
Number of subjects: 35
Study: 8932457

Group type: EXPERIMENTAL
Intervention: Test suspensions
Number of subjects: 0

Group type: COMPARATOR
Intervention: Reference formulation
Number of subjects: 0
Study: 1881558

Group type: EXPERIMENTAL
Intervention: Picotamide (900 mg/die)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study: 7051249

Group type: EXPERIMENTAL
Intervention: Trimethoprim-sulfamethoxazole (TMP-SMZ) 160 mg of TMP plus 800 mg of SMZ daily for four months
Number of subjects: 52

Group type: COMPARATOR
Intervention: No prophylaxis
Number of subjects: 52
Study: 31470971

Group type: EXPERIMENTAL
Intervention: Active intervention group (AG) - integrated intervention program
Number of subjects: 368

Group type: EXPERIMENTAL
Intervention: Passive intervention group (PG) - oral health-related information and activity record cards
Number of subjects: 368

Group type: COMPARATOR
Intervention: Control group (CG) - received only a lecture
Number of subjects: 368

Group type: EXPERIMENTAL
Intervention: Active intervention group (AG)
Number of subjects: 368

Group type: EXPERIMENTAL
Intervention: Passive intervention group (PG)
Number of subjects: 368

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 368
Study: 28453701

Group type: EXPERIMENTAL
Intervention: Radium-223
Number of subjects: 921

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 921